Dr. Stephen Firshein, MD
85 Seymour St, Suite 901, Hartford, CT 06106 • +1-845-555-1436
Medical Education: Accredited U.S. Medical School (Class of 2010)
What This Doctor Actually Performs: CMS Medicare Utilization & Hartford Percentiles
NPI #1467557694 • CBSA Regional • Hematology-Oncology
Operating out of Hartford, CT (85 Seymour St, Suite 901), Hematology-Oncology clinician Dr. Stephen Firshein, MD (accredited MD/DO training, 2010) maintains a upper-quartile active clinical volume (87.5th Hartford percentile) (95.52th CT percentile; Z-score +2.60σ across 161,362 documented services) with sub-specialty concentration in 110 Active CMS HCPCS Codes.
Procedural volume for Dr. Firshein is led by HCPCS 99214 (Moderate-to-High Complexity Internal Medicine Follow-Up — 1456 annual services, $43–$60 GPCI cash estimate), followed by CPT 99213 (Established Preventive & Chronic Care Visit, 841/yr) and CPT 93000 (In-Office 12-Lead Resting Electrocardiogram, 421/yr).
Cash-pay intake data for NPI 1467557694 (85 Seymour St, Suite 901, Hartford) indicates $209.00 typical out-of-pocket visit spend against a $209.00 locality benchmark, paired with 19-minute average reception wait and 4.53/5 biomarker openness.
Credentialed as an MD specialist with 16 years post-graduation experience since completing medical school at an LCME/COCA institution (2010), Dr. Firshein coordinates 110 Active CMS HCPCS Codes workups from 85 Seymour St, Suite 901 (+1-845-555-1436).
Compared against Hartford, CT Hematology-Oncology peers
161,362 annual services across 513 beneficiaries
Standard deviations from CT Hematology-Oncology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Moderate-to-High Complexity Internal Medicine Follow-Up | 1,456 | 87.5th | $43 – $60 |
| 99213 | Established Preventive & Chronic Care Visit | 841 | 87.5th | $33 – $48 |
| 93000 | In-Office 12-Lead Resting Electrocardiogram | 421 | 83.5th | $25 – $40 |
| G0439 | Annual Preventive Wellness & Cardiometabolic Risk Assessment | 324 | 82.5th | $51 – $70 |
| 99204 | Comprehensive New Patient Internal Medicine Diagnostic Visit | 194 | 91.5th | $60 – $83 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (110 HCPCS billing breadth) | 158,126 | 87.5th | $45 – $65 |
Are you Dr. Stephen Firshein? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Hartford, CT:
<a href="https://dotmd.com/doctors/stephen-firshein-md-hartford-ct-1467557694" title="Dr. Stephen Firshein, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1467557694.svg" alt="Dr. Stephen Firshein Hematology-Oncology Badge" width="280" height="72" /></a>
Dr. Stephen Firshein, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Firshein National Provider Identifier | NPI #1467557694 (MD) | CMS NPPES Registry (06106) |
| Dr. Firshein Hartford CMS Volume Rank | 87.50th Pct (161,362 CMS svcs; Z +2.597σ) | CMS Medicare Part B (CT Hematology-Oncology) |
| Fair Cash-Pay New-Patient Benchmark | $209.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Hartford, CT) |
| Waiting-Room Wait Time & Cash Friendliness | $209.00 avg paid • 19 min lobby wait | 15 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.89/5 Listening • 4.53/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Stephen Firshein
Other High-Volume Hematology-Oncology Specialists in Hartford, CT
Ranked strictly by CMS Medicare volumeDr. Firshein Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Hartford, CT.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Stephen Firshein community threads and patient logs by age, biological sex, dosage, and treatment duration.